Emerald Clinical’s team will be attending ESMO Asia 2025, December 5-7 in Singapore.
Book a Meeting with Us
Meet our Oncology Therapeutic Strategy Director and Head of China and Global Partnerships at ESMO Asia 2025.
Beyond Partners: Collaborators in your Oncology clinical development programs.
ESMO Asia is where global Oncology professionals come to collaborate about groundbreaking discoveries and cutting-edge treatments to shape the future of cancer care. It’s the perfect opportunity to meet with Emerald Clinical Trials’ experienced Oncology team, who blends scientific integrity with operational intelligence to accelerate and enhance your oncology drug development program.
Emerald Clinical has conducted over 440 oncology studies enrolling nearly 69,000 patients with 25% of those being Early Phase. Our long-standing relationships with global Oncology KOLs differentiate our collaborations. Their clinical experience combined with Emerald’s operational expertise ensure that your study addresses a real clinical need, is efficiently executed, respects patients, and will transition smoothly through phases and regulatory approvals.
As most people globally have been impacted by cancer in some way, be it a personal diagnosis, or that of a family member or friend, our goal at Emerald Clinical is to drive the successful delivery of novel oncology assets to these patients. We want to ensure that we are providing impactful services for our clients, and ultimately the patients. This success is driven by a cohesive team of dedicated professionals that strive to ensure assets are available globally.
Therapeutic Strategy Director, Oncology
Why Emerald Clinical? ADD BIT ABOUT APAC EXPERIENCE
The Emerald Clinical Oncology Advantage: We’ve done that. We can help you do it better.
Our oncology team has over 20 years of cross-functional industry experience in all study aspects and expertise in:
- Creating early strategies that lead to faster regulatory approval and commercialization
- Navigating rapidly shifting global regulatory environments
- Strong feasibility studies for better site identification
- Engaging Oncology KOLs for advice leading to faster recruitment and higher retention levels
- Dedicated Early Phase teams and assistance with Australian R&D tax benefits
- Access to qualified sites and patients in 70 countries
Learn more about our oncology scientific experts team and our oncology expertise.
Meet our Team
Learn more about our Oncology Capabilities
Peyni Chan
Peyni brings more than 20 years of leadership experience in clinical research and business development…
Yoshihiro (Yoshi) Takizawa
Yoshi is a seasoned business development professional with over 10 years of experience in the…
Jonathan Gobres BS Pharmacy
Jonathan designs bespoke, region‑specific strategies for trials across APAC and the rest of the world.…
